Face filler expected to soar with cases of gaunt ‘Ozempic face’ — and one company is cashing in
- Oops!Something went wrong.Please try again later.
A saggy, sunken face is a hallmark of Ozempic use, but one pharmaceutical company wants to fix that.
Dubbed “Ozempic face,” a term coined by celebrity dermatologist Dr. Paul Jarrod Frank, the gaunt appearance is a growing adverse effect of the weight loss drug due to a loss of facial volume, which Flemming Ornskov, the CEO of the Swiss skincare giant Galderma, wants to solve with filler.
“I think that will be another growth wave in that space, which I will make sure to capture,” Ornskov told Bloomberg, referring to the anticipated surge of facial filler requests as a result of Ozempic use.
Galderma is now studying the efficacy of fillers like Sculptra and Restylane “for cheek augmentation and contour deficiencies in GLP-1 patients,” a spokesperson told Business Insider.
The filler then can restore some of the plumpness in the face, which becomes deflated after losing excessive weight quickly.
The Post has reached out to Galderma representatives for further comment.
Experts previously told Everyday Health that extreme weight loss in less than six months can cause a loss of skin elasticity due to the disruption of the skin barrier and the “rapid depletion of the essential fatty acids.” The result is a lusterless, thin, drooping complexion.
Plastic surgeons have also warned of the ill effects of the GLP-1 agonist jab that are seemingly taking over Hollywood, pointing to celebs like John Goodman and Robbie Williams.
Sharon Osbourne is perhaps the most extreme and “dramatic” example, experts said, having lost a reported 42 pounds on the Novo Nordisk drug.
“Her eyes look more sunken in, her cheeks have more hollowing,” New Jersey plastic surgeon Dr. Smita Ramanadham previously told the Daily Mail.
“There is a significant loss in facial volume as well, and more wrinkling that is associated with it.”
Reality star Scott Disick recently sparked concern over his suddenly slender appearance after what appears to be a dramatic weight loss due to allegedly taking Ozempic. After “public outcry” over his emaciated frame, however, an inside source told the Daily Mail that he would be quitting the drug.
“Scott recognized that he needed to stop taking Ozempic after seeing the photos of himself and the public outcry over his weight loss,” the anonymous source claimed.
But a sagging mug is not the only side effect of the buzzy jab, which has faced a frenzy of sorts, resulting in supply shortages and, subsequently, an influx of counterfeit medication to supplement the demand.
Ozempic has been linked to bowel obstruction, foul belches, gastrointestinal distress and stomach paralysis.
